ProShares UltraShort Nasdaq Biotechnology BIS

The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

NDAQ:BIS - Post by User

ProShares UltraShort Nasdaq Biotechnology > Looks like biotech short is in major play

<< Previous

Bullboard Posts

Comment by mdaffinon Sep 29, 2015 3:34pm

199 Views

Post# 24146384

RE:RE:Looks like biotech short is in major play

Wow - sentiment has really changed. LABD has doubled in a week and BIS is up 50 % since I started trading this (mainly badly, so don't think I made a lot). LABD/U stocks are all the non money making biotech, while BIS/BIB has some moneymaking (but its biotech, so mainly money loosing). These ETF's are also useful for determining overall market direction.

I think LABD could hit 90 and BIS 60, but who knows if it can go higher.

<< Previous

Bullboard Posts

A junior copper-gold stock trading at a bargain of monumental proportions